Progressive insulin-derived amyloidosis in a patient with type 2 diabetes

Here, we report a case of insulin-derived amyloidosis in the lower abdomen. The mass continued to develop even after the patient ceased injecting insulin into the mass. Histological examination led to a diagnosis of insulin-derived amyloidosis. Excision is preferable in cases of insulin-derived amyl...

Descripción completa

Detalles Bibliográficos
Autores principales: Shiba, Masato, Kitazawa, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095519/
https://www.ncbi.nlm.nih.gov/pubmed/27882336
http://dx.doi.org/10.1080/23320885.2016.1247650
_version_ 1782465298391105536
author Shiba, Masato
Kitazawa, Takeshi
author_facet Shiba, Masato
Kitazawa, Takeshi
author_sort Shiba, Masato
collection PubMed
description Here, we report a case of insulin-derived amyloidosis in the lower abdomen. The mass continued to develop even after the patient ceased injecting insulin into the mass. Histological examination led to a diagnosis of insulin-derived amyloidosis. Excision is preferable in cases of insulin-derived amyloidosis if patient’s condition permits.
format Online
Article
Text
id pubmed-5095519
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Taylor & Francis
record_format MEDLINE/PubMed
spelling pubmed-50955192016-11-23 Progressive insulin-derived amyloidosis in a patient with type 2 diabetes Shiba, Masato Kitazawa, Takeshi Case Reports Plast Surg Hand Surg Case Report Here, we report a case of insulin-derived amyloidosis in the lower abdomen. The mass continued to develop even after the patient ceased injecting insulin into the mass. Histological examination led to a diagnosis of insulin-derived amyloidosis. Excision is preferable in cases of insulin-derived amyloidosis if patient’s condition permits. Taylor & Francis 2016-10-31 /pmc/articles/PMC5095519/ /pubmed/27882336 http://dx.doi.org/10.1080/23320885.2016.1247650 Text en © 2016 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group. http://creativecommons.org/licenses/by-nc/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Shiba, Masato
Kitazawa, Takeshi
Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title_full Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title_fullStr Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title_full_unstemmed Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title_short Progressive insulin-derived amyloidosis in a patient with type 2 diabetes
title_sort progressive insulin-derived amyloidosis in a patient with type 2 diabetes
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5095519/
https://www.ncbi.nlm.nih.gov/pubmed/27882336
http://dx.doi.org/10.1080/23320885.2016.1247650
work_keys_str_mv AT shibamasato progressiveinsulinderivedamyloidosisinapatientwithtype2diabetes
AT kitazawatakeshi progressiveinsulinderivedamyloidosisinapatientwithtype2diabetes

Ejemplares similares